Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/000456328902600618 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diabetes technology in people with diabetes and advanced chronic kidney disease.
Diabetologia
October 2024
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Diabetes is the leading cause and a common comorbidity of advanced chronic kidney disease. Glycaemic management in this population is challenging and characterised by frequent excursions of hypoglycaemia and hyperglycaemia. Current glucose monitoring tools, such as HbA, fructosamine and glycated albumin, have biases in this population and provide information only on mean glucose exposure.
View Article and Find Full Text PDFEffect of Optimization of Glycaemic Control on Mannan-Binding Lectin in Type 1 Diabetes.
J Diabetes Res
August 2018
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, 8000 Aarhus, Denmark.
Article Synopsis
- Mannan-binding lectin (MBL) levels are higher in type 1 diabetes patients and linked to greater mortality and diabetic nephropathy risk; pancreas transplants lower MBL, but the impact of glycaemic control on MBL is unclear.
- In a study of 52 type 1 diabetes patients switching to insulin pumps, there was a significant reduction in insulin dosage and improvements in HbA1c and fructosamine after 6 weeks.
- MBL levels decreased by 10% post-treatment, but the change in MBL did not correlate with improvements in insulin dose or blood sugar measures.
Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
Pediatr Diabetes
March 2004
Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030-2399, USA.
Objective: The aim of continuous subcutaneous insulin infusion (CSII) therapy in patients with type 1 diabetes mellitus (T1DM) is to mimic as closely as possible the normal physiologic pattern seen in individuals without diabetes. This study was undertaken to determine the specific areas of improved glycemic control in subjects after initiation of insulin pump therapy and times where further improvement is needed.
Research Design And Methods: Eight patients with T1DM (age 7.
Fructosamine assay using albumin extracted from serum.
Biol Pharm Bull
September 2002
Faculty of Pharmaceutical Sciences, Teikyo University, Tsukui-gun, Kanagawa, Japan.
Albumin extracted from serum by a simple technique using trichloroacetic acid and ethanol has been applied to a fructosamine assay using nitroblue tetrazolium. A fructosamine assay using extracted albumin sample was carried out without interference from low molecular weight substances with reducing activities and other proteins with varying concentrations, half-lives and reducing activities. 1-Deoxy-1-p-toluidino-D-fructose (DTF) was selected as a calibrator for the assay because it is a stable Amadori reaction product with a constant glycation rate.
View Article and Find Full Text PDFGlucose monitoring in type 2 diabetes.
Nurs Clin North Am
June 2001
Loyola University Medical Center, Maywood, Illinois 60153, USA.
A major goal in the treatment of type 2 diabetes is to maintain blood glucose values in the normal or near normal range. A system of monitoring glycemic control, which includes self-monitoring of blood glucose (SMBG) by the patient, and frequent glycated protein assays, is an important tool for achieving this goal. Optimal use of SMBG by the patient is best accomplished through comprehensive glucose monitoring education, which includes appropriate monitor selection and use and strategies to use monitoring results to improve glycemic control.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!